cc-292 has been researched along with Hematologic-Neoplasms* in 1 studies
1 other study(ies) available for cc-292 and Hematologic-Neoplasms
| Article | Year |
|---|---|
Development of novel hydrazidoarylaminopyrimidine-based BTK/FLT3 dual inhibitors with potent in vivo anti-hematological malignancies effects.
Topics: Acrylamides; Animals; Apoptosis; Disease Models, Animal; fms-Like Tyrosine Kinase 3; Hematologic Neoplasms; Humans | 2023 |